Ecm Therapeutics, Inc

ECM Therapeutics is a clinical-stage regenerative medicine company focused on developing extracellular matrix–based materials that support the body’s natural healing processes. The company’s lead wound care product is designed for challenging wounds such as diabetic foot ulcers, venous leg ulcers, and pressure injuries, as well as complex wounds including tunneling and draining wounds where maintaining stable tissue contact can be difficult. The material is designed to conform to wound geometry and remain in place in wet environments. ECM Therapeutics plans market entry for its wound care product in 2027. In parallel, the company is advancing additional ECM-based healing technologies, including front-of-eye surface repair, and is conducting an ongoing clinical IDE study evaluating its technology for fistula repair.